Related Experiment Videos
Monoamine influence on neuropeptide gene expression during ontogenesis
M V Ugrumov1, A Trembleau, D Roche
1Laboratory of Hormonal Regulations, Russian Academy of Sciences, Moscow.
Acta Biologica Hungarica
|January 1, 1994
Summary
Monoamines inhibit peptide gene expression in developing neurons. Catecholamine depletion increased vasopressin and oxytocin mRNA in neonates, while serotonin depletion affected vasoactive intestinal polypeptide mRNA in fetal rats.
Area of Science:
- Neuroscience
- Developmental Biology
- Molecular Biology
Background:
- Monoamines play crucial roles in neuronal development.
- Understanding monoamine influence on neuropeptide gene expression is vital for developmental neuroscience.
Purpose of the Study:
- To investigate the hypothesis of monoamine regulation on target neuron differentiation during ontogenesis.
- To evaluate the impact of monoamine depletion on neuropeptide gene expression in developing neurons.
Main Methods:
- In situ hybridization was used to measure neuropeptide mRNA levels (vasopressin, oxytocin, vasoactive intestinal polypeptide).
- Monoamine depletion was achieved using specific inhibitors (alpha-methyl-m(p)-tyrosine, p-chlorophenylalanine) and a neurotoxin (6-hydroxydopamine) in prenatal and early postnatal rats.
- Experiments focused on the supraoptic nucleus (SON) and suprachiasmatic nucleus (SCN).
Main Results:
- Catecholamine depletion did not alter vasopressin (VP) and oxytocin (OT) mRNA in fetal rats but significantly increased them in neonates.
- Serotonin (5-HT) depletion increased vasoactive intestinal polypeptide (VIP) mRNA in fetal rats but not in neonates.
- These findings indicate a time-dependent inhibitory effect of monoamines on peptide gene expression.
Conclusions:
- Monoamines exert an inhibitory influence on peptide gene expression in differentiating target neurons.
- This regulatory effect is specific to certain developmental periods during ontogenesis.
- The study highlights the complex interplay between monoamines and neuropeptide systems during neural development.